Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3949/ccjm.87a.ccc008 http://scihub22266oqcxt.onion/10.3949/ccjm.87a.ccc008 32393592!ä!32393592 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cleve+Clin+J+Med 2020 ; 87 (7): 389-393 Nephropedia Template TP {{tp|p=32393592|t=2020. Cytokine storm and the prospects for immunotherapy with COVID-19 |pdf=|usr=}}{{32393592}} gab.com Text Cytokine storm and the prospects for immunotherapy with COVID-19 JO: Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393592 #FOAvip Knowledge about the pathobiology of SARS-CoV-2 as it interacts with immune defenses is limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes. COVID-19 is characterized by 2 or 3 stages: most patients who recover experience 2 stages of illness commencing with an asymptomatic or paucisymptomatic incubation period, followed by a nonsevere symptomatic illness lasting for several weeks, occurring in about 80% of those infected. In the remainder, a third phase marked by a severe respiratory illness, often accompanied by multisystem dysfunction, coagulopathy, and shock is observed. This phase of the illness is characterized by hypercytokinemic inflammation and is often referred to as "cytokine storm." While the immunopathogenesis remains unclear, prospects of treating this severe phase of the illness with immunotherapy are evolving, with some treatments showing promise. Twit Text FOAVip Cytokine storm and the prospects for immunotherapy with COVID-19 ????Cleve Clin J Med http://www.kidney.de/pget.php?&tw=1&pmid=32393592 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32393592 #FOAvip English Wikipedia <ref>{{Cite pmid|32393592}}</ref> Cytokine storm and the prospects for immunotherapy with COVID-19 #MMPMID32393592 Calabrese LH Cleve Clin J Med 2020[Jun]; 87 (7): 389-393 PMID32393592show ga Knowledge about the pathobiology of SARS-CoV-2 as it interacts with immune defenses is limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes. COVID-19 is characterized by 2 or 3 stages: most patients who recover experience 2 stages of illness commencing with an asymptomatic or paucisymptomatic incubation period, followed by a nonsevere symptomatic illness lasting for several weeks, occurring in about 80% of those infected. In the remainder, a third phase marked by a severe respiratory illness, often accompanied by multisystem dysfunction, coagulopathy, and shock is observed. This phase of the illness is characterized by hypercytokinemic inflammation and is often referred to as "cytokine storm." While the immunopathogenesis remains unclear, prospects of treating this severe phase of the illness with immunotherapy are evolving, with some treatments showing promise. |*Betacoronavirus/isolation & purification/physiology[MESH] |*Coronavirus Infections/immunology/physiopathology/therapy/virology[MESH] |*Immunologic Factors/classification/pharmacology[MESH] |*Inflammation/immunology/virology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/immunology/physiopathology/therapy/virology[MESH] |COVID-19[MESH] |Cytokine Release Syndrome/etiology/*immunology[MESH] |Disease Progression[MESH] |Humans[MESH] |Immunity[MESH] |Immunotherapy/*methods[MESH] |Patient Acuity[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH]Cytokine storm and the prospects for immunotherapy with COVID-19 (epmc).pdf DeepDyve Pubget Overpricing